Annotated Medicine and Device Lists
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fentanyl | Injection | 0.05 mg/mL | |
| flunitrazepam | Injection | 2 mg in vial | |
| halothane | Solution | 250 mL | |
| isoflurane | Solution | 250 mL | |
| ketamine | Injection | 10 mg/20 mL | |
| ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
| midazolam | Injection | 5 mg/mL | |
| nitrous oxide | Inhalation | N/A | |
| propofol | Injection | 10 mg/mL | |
| thiopental | Powder for injection | 0.5 g (as sodium) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bupivacaine | Injection | 0.5% (hydrochloride) in 5 mL vial | |
| lidocaine | Gel | 2% | |
| lidocaine | Injection | 2% (hydrochloride) (without preservant) in 2 mL vial | |
| lidocaine | Injection | 2% (hydrochloride) in 2 mL ampoule | |
| lidocaine | Injection | 2% (hydrochloride) with preservant in 20 mL vial | |
| lidocaine | Injection | 2% (hydrochloride) with preservant in 5 mL vial | |
| lidocaine | Injection | 5% (hydrochloride, hyperbaric) in 3 mL ampoule | |
| lidocaine | Spray | 10% (hydrochloride) | |
| lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:50 000 | |
| lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
| mepivacaine | Dental cartridge | 3% | |
| mepivacaine | Injection | 2% in 20 mL vial | |
| tetracaine | Injection | 100 mg in 10 mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Injection | 0.5 mg/mL | |
| diazepam | Injection | 10 mg in 2-mL ampoule | |
| nalbuphine hydrochloride | Injection | 20 mg in vial | |
| pancuronium | Injection | 2 mg (bromuro)/mL | |
| succinylcholine chloride | Injection | 1 g in 20-mL vial | |
| succinylcholine chloride | Powder for injection | 1 g (lyophilized) in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 125 mg | |
| acetylsalicylic acid | Tablet | 500 mg | |
| diclofenac | Injection | 25 mg (sodium)/mL | |
| dipyrone (metamizole sodium) | Injection | 600 mg in 2-mL ampoule | |
| dipyrone (metamizole sodium) | Suppository | 300 mg | c2 |
| dipyrone (metamizole sodium) | Tablet | 300 mg | |
| ibuprofen | Suspension | 100 mg/5 mL | |
| ibuprofen | Tablet | 400 mg | |
| indomethacin | Injection | 1 mg (sodium salt) | |
| indomethacin | Tablet | 25 mg | |
| naproxen | Tablet | 250 mg (sodium) | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Suppository | 300 mg | c2 |
| paracetamol | Tablet | 500 mg | |
| piroxicam | Suppository | 20 mg | |
| piroxicam | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| codeine | Oral liquid | 30 mg/15 mL | |
| codeine | Tablet | 30 mg | |
| morphine | Injection | 10 mg (hydrochloride)/mL | |
| morphine | Injection | 2 mg in 5-mL vial | |
| morphine | Injection | 20 mg (hydrochloride)/mL | |
| nalbuphine hydrochloride | Injection | 20 mg in vial | |
| pethidine | Injection | 50 mg (hydrochloride) in 1-mL ampoule | |
| pethidine | Injection | 100 mg in 2-mL ampoule | |
| tramadol | Injection | 100 mg (hydrochloride)/2 mL | |
| tramadol | Oral liquid | 100 mg (hydrochloride)/mL (as drops) | |
| tramadol | Tablet | 50 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| allopurinol | Tablet | 100 mg | |
| probenecid | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azathioprine | Tablet | 50 mg | |
| chloroquine | Tablet | 150 mg | |
| ciclosporin | Tablet | 25 mg | |
| methotrexate | Injection | 500 mg | |
| methotrexate | Tablet | 2.5 mg | |
| penicillamine | Tablet (enteric-coated) | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cyproheptadine | Tablet | 4 mg | |
| dexchlorpheniramine maleate | Tablet | 2 mg | |
| diphenhydramine | Injection | 20 mg in 2-mL ampoule | |
| diphenhydramine | Oral liquid | 12.5 mg/5 mL | |
| diphenhydramine | Tablet | 25 mg | |
| loratadine | Oral liquid | 5 mg/mL | |
| loratadine | Tablet | 10 mg | |
| meclizine hydrochloride | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcysteine | Injection | 200 mg in 1-mL ampoule | |
| acetylcysteine | Powder for oral administration | 200 mg | |
| acetylcysteine | Powder for oral administration | 200 mg | |
| atropine | Injection | 0.5 mg (sulphate) in 1-mL ampoule | |
| deferoxamine | Powder for injection | 500 mg (mesilate) in vial | |
| dicobalt edetate (cobalt EDTA) | Injection | 300 mg in 20-mL ampoule | |
| dimercaprol | Injection in oil | 50 mg/mL in 2-mL ampoule | |
| ethyl alcohol (ethanol) | Injection | 96% in 10-mL ampoule | |
| flumazenil | Injection | 0.5 mg/mL | |
| methylthioninium chloride (methylene blue) | Injection | 10 mg/mL in 20-mL ampoule | |
| naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
| obidoxime | Injection | 250 mg (chloride)/mL | |
| obidoxime | Injection | 250 mg (chloride)/mL | |
| penicillamine | Tablet (enteric-coated) | 250 mg | |
| potassium ferric hexacyano-ferrate(II) - 2H20 (Prussian blue) | Capsule | 500 mg | |
| protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule | |
| sodium calcium edetate | Injection | 50 mg/mL in 20 mL ampoule | |
| sodium nitrite | Injection | 30 mg/mL in 10-mL ampoule | |
| sodium thiosulfate | Injection | 250 mg/mL in 50-mL ampoule | |
| trientine | Capsule | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| charcoal, activated | Powder for oral administration | 1-kg bag |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbamazepine | Tablet | 200 mg | |
| clonazepam | Tablet | 1 mg | |
| diazepam | Injection | 10 mg in 2-mL ampoule | |
| diazepam | Tablet | 5 mg | |
| ethosuximide | Tablet | 250 mg | |
| gabapentin | Tablet | 300 mg | |
| lamotrigine | Tablet | 100 mg | |
| magnesium sulfate | Injection | 10% | |
| phenobarbital | Injection | 200 mg (sodium)/mL | |
| phenobarbital | Oral liquid | 15 mg/5 mL | |
| phenobarbital | Tablet | 100 mg | |
| phenobarbital | Tablet | 15 mg | |
| phenytoin | Oral liquid | 125 mg/5 mL | |
| phenytoin | Powder for injection | 250 mL in vial | |
| phenytoin | Tablet (chewable) | 50 mg | |
| piracetam | Injection | 1 g/mL in vial | |
| piracetam | Suspension | 1 g/125 mL | |
| piracetam | Tablet | 800 mg | |
| primidone | Suspension | 200 mg/5 mL | |
| primidone | Tablet | 250 mg | |
| topiramate | Tablet | 100 mg | |
| valproic acid (sodium valproate) | Oral liquid | 250 mg/5 mL | |
| valproic acid (sodium valproate) | Tablet | 500 mg | |
| vigabatrin | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diloxanide | Tablet | 500 mg (furoate) | |
| metronidazole | Gel | 0.75% | |
| metronidazole | Injection | 500 mg in 100-mL vial | |
| metronidazole | Tablet | 250 mg | |
| metronidazole | Vaginal tablet | 500 mg | |
| quinacrine hydrochloride | Tablet | 100 mg | |
| secnidazole | Tablet | 500 mg | |
| tinidazole | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloroquine | Tablet | 150 mg | |
| halofrantine | Tablet | 250 mg | |
| mefloquine | Tablet | 250 mg (hydrochloride) | |
| pirimetamine | Tablet | 25 mg | |
| primaquine | Tablet | 15 mg (phosphate) | |
| quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule | |
| quinine | Tablet | 500 mg | |
| sulfadoxine + pyrimethamine | Tablet | 500 mg + 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pentamidine | Powder for injection | 300 mg (isetionate) in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albendazole | Tablet | 500 mg | |
| ivermectin | Tablet | 6 mg | |
| levamisole | Oral liquid | 5 mg/mL | |
| levamisole | Tablet | 150 mg (as hydrochloride) | |
| mebendazole | Tablet | 100 mg | |
| piperazine | Oral liquid | 1.5 g/15 mL | |
| thiabendazole | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| praziquantel | Tablet | 600 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzyl benzoate | Topical forms | 10% | |
| permethrin | Cream | 5% | |
| permethrin | Lotion | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amoxicillin | Capsule | 500 mg | |
| amoxicillin | Powder for oral liquid | 125 mg (as trihydrate)/5 mL | |
| amoxicillin + sulbactam | Powder for injection | amoxicillin (sodium) 500 mg + sulbactam (sodium) 250 mg in vial | |
| amoxicillin + sulbactam | Tablet | amoxicillin 250 mg (sodium) + sulbactam (sodium) 250 mg | |
| amoxicillin + sulbactam | Tablet | amoxicillin 250 mg (sodium) + sulbactam (sodium) 250 mg | |
| ampicillin | Capsule | 500 mg | |
| ampicillin | Oral liquid | 125 mg/5 mL (anhydrate or trihydrate) | |
| ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
| aztreonam | Powder for injection | 1 g | |
| benzathine benzylpenicillin | Injection | 1 200 000 IU | |
| cloxacillin | Powder for injection | 500 mg (sodium salt) | |
| meropenem | Injection | 500 mg | |
| meropenem | Powder for injection | 1 g | |
| oxacillin | Capsule | 250 mg | |
| piperacillin + beta-lactamase inhibitor | Injection | piperacillin 1 g + 250 mg beta-lactamase inhibitor (tazobactam) | |
| piperacillin sodium | Injection | 1 g in vial | |
| sodium benzylpenicillin | Injection | 1,000,000 IU | |
| sodium benzylpenicillin + procaine benzylpenicillin | Injection | sodium benzylpenicillin 200 000 U + procaine benzylpenicillin 800 000 U |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clofazimine | Capsule | 100 mg | |
| cycloserine | Solid oral dosage form | 250 mg | |
| dapsone | Tablet | 100 mg | |
| ethambutol | Tablet | 250 mg | |
| ethionamide | Tablet | 250 mg | |
| isoniazid | Tablet | 150 mg | |
| pyrazinamide | Tablet | 500 mg | |
| rifabutin | Capsule | 150 mg | |
| rifampicin | Capsule | 300 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cefalexin | Capsule | 500 mg | |
| cefalexin | Oral liquid | 125 mg/5 mL | |
| cefazolin | Powder for injection | 1 g (as sodium salt) in vial | |
| cefazolin | Powder for injection | 250 mg (as sodium salt) | |
| cefepime | Injection | 1 g in vial | |
| cefotaxime | Powder for injection | 1 g (as sodium salt) | |
| ceftazidime | Injection | 1 g | |
| ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
| cefuroxime | Injection | 750 mg in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amikacin | Injection | 500 mg (sulfate)/2 mL | |
| gentamicin | Cream | 0.1% | |
| gentamicin | Injection | 20 mg (sulfate)/2 mL | |
| gentamicin | Injection | 80 mg (sulfate)/2 mL | |
| kanamycin | Injection | 200 mg (sulfate)/mL in vial | |
| kanamycin | Injection | 50 mg (sulfate)/mL in ampoule | |
| streptomycin | Powder for injection | 1 g (as sulfate) in vial | |
| tobramycin | Injection | 100 mg (sulfate) in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azithromycin | Tablet | 250 mg | |
| azithromycin | Tablet | 500 mg | |
| clarithromycin | Tablet | 500 mg | |
| clindamycin | Injection | 600 mg | |
| clindamycin | Tablet | 300 mg | |
| erythromycin | Oral liquid | 125 mg (estolate)/5 mL | |
| erythromycin | Powder for injection | 1 g (lactiobonate) | |
| erythromycin | Tablet (enteric-coated) | 250 mg (stearate) | |
| spiramycin | Tablet | 1.5 MMU (3200 U=1 mg spiramycin) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| doxycycline | Capsule | 100 mg | |
| minocycline | Tablet | 50 mg | |
| tetracycline | Capsule | 100 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloramphenicol | Powder for injection | 1 g (sodium succinate) in vial | |
| chloramphenicol | Suspension | 125 mg (palmitate)/5 mL | |
| chloramphenicol | Tablet (enteric-coated) | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sulfadiazine | Injection | 10% sulfadiazine (sodium) | |
| sulfadiazine | Tablet | 500 mg | |
| sulfamethoxazole + trimethoprim | Injection | 400 mg + 80 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Oral liquid | 100 mg + 20 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
| sulfathiazole | Vaginal tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ciprofloxacin | Solution for IV infusion | 200 mg in 100 mL vial | |
| ciprofloxacin | Tablet (enteric-coated) | 250 mg (hydrochloride) | |
| levofloxacin | Injection | 500 mg/100 mL vial | |
| levofloxacin | Tablet | 500 mg | |
| nalidixic acid | Suspension | 250 mg/5mL | c2 |
| nalidixic acid | Tablet | 500 mg | |
| norfloxacin | Tablet | 400 mg | |
| ofloxacin | Tablet | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| methenamine mandelate (mandelamine) | Tablet | 500 mg | |
| nitrofurantoin | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| linezolid | Tablet | 600 mg | |
| phosphomycin | Capsule | 500 mg | |
| phosphomycin | Injection | 1 g in vial | |
| rifamycin | Injection | 250 mg (sodium) in vial | |
| teicoplanin | Injection | 200 mg in ampoule | |
| vancomycin | Injection | 500 mg (chlorohydrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amphotericin B | Powder for injection | 50 mg in vial | |
| clotrimazole | Cream | 1% | |
| clotrimazole | Vaginal tablet | 500 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| fluconazole | Oral liquid | 200 mg/5 mL | |
| fluconazole | Tablet | 150 mg | |
| flucytosine | Capsule | 250 mg | |
| itraconazole | Capsule | 100 mg | |
| ketoconazole | Cream | 2% | |
| ketoconazole | Tablet | 200 mg | |
| ketoconazole | Vaginal tablet | 400 mg | |
| miconazole | Cream | 2% (nitrate) | |
| miconazole | Injection | 0.5 mg/mL | |
| nystatin | Cream | 100 000 IU/g | |
| nystatin | Oral liquid | 500 000 IU/5 mL | |
| nystatin | Tablet (enteric-coated) | 500 000 IU | |
| nystatin | Vaginal tablet | 100 000 IU |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aciclovir | Cream | 5% | |
| aciclovir | Powder for injection | 250 mg | |
| aciclovir | Tablet | 200 mg | |
| adefovir dipivoxil | Tablet | 10 mg | |
| didanosine (ddI) | Tablet | 100 mg | |
| ganciclovir | Injection | 500 mg (sodium) | |
| indinavir (IDV) | Capsule | 200 mg | |
| lamivudine (3TC) | Tablet | 150 mg | |
| nevirapine (NVP) | Tablet | 200 mg | |
| oseltamivir | Capsule | 75 mg (as phosphate) | |
| oseltamivir | Powder for oral administration | 20 mg/5 mL | |
| ribavirin | Tablet | 400 mg | |
| stavudine (d4T) | Capsule | 40 mg | |
| valgancyclovir | Tablet | 450 mg | |
| zidovudine (ZDV or AZT) | Capsule | 100 mg | |
| zidovudine (ZDV or AZT) | Injection | 10 mg/mL | |
| zidovudine (ZDV or AZT) | Tablet | 300 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 125 mg | |
| acetylsalicylic acid | Tablet | 500 mg | |
| dihydroergotamine mesylate | Injection | 1 mg/mL in ampoule | |
| ergotamine + caffeine | Tablet | 1 mg (tartrate) + 100 mg | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Suppository | 300 mg | c2 |
| paracetamol | Tablet | 500 mg | |
| sumatriptan | Injection | 12 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cyproheptadine | Tablet | 4 mg | |
| propanolol | Injection | 1 mg/mL | |
| propanolol | Tablet | 10 mg | |
| propanolol | Tablet | 40 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anti-human thymocyte immunoglobulin (equine) | Injection | 250 mg in 5 mL vial | |
| azathioprine | Tablet | 50 mg | |
| basiliximab | Powder for injection | 20 mg | |
| CD3 monoclonal antibody | Intravenous administration | 5 mg in 5 mL vial | |
| cyclophosphamide | Injection | 1 g | |
| cyclophosphamide | Injection | 200 mg | |
| cyclophosphamide | Tablet | 50 mg | |
| cyclosporine | Tablet | 100 mg | |
| everolimus | Tablet | 0.75 mg | |
| mycophenolate mofetil | Tablet | 500 mg | |
| mycophenolate sodium | Tablet | 360 mg | |
| tacrolimus | Capsule | 0.5 mg | |
| tacrolimus | Capsule | 1 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| busulfan | Tablet | 2 mg | |
| carmustine | Injection | 100 mg | |
| chlorambucil | Tablet | 2 mg | |
| dacarbazine | Injection | 200 mg | |
| ifosfamide | Powder for injection | 1 g in vial | |
| melphalan | Tablet | 2 mg | |
| mitomycin | Injection | 10 mg in vial | |
| procarbazine | Capsule | 50 mg (as hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carboplatin | Injection | 150 mg | |
| carboplatin | Injection | 450 mg | |
| cisplatin | Powder for injection | 10 mg in vial | |
| cisplatin | Powder for injection | 50 mg in vial | |
| oxaliplatin | Injection | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
| dactinomycin | Powder for injection | 500 mcg in vial | |
| doxorubicin | Powder for injection | 10 mg in vial | |
| doxorubicin | Powder for injection | 50 mg in vial | |
| etoposide | Powder for injection | 100 mg | |
| idarubicin | Powder for injection | 5 mg in 5 mL vial | |
| mitoxantrone | Injection | 2 mg/mL | |
| teniposide | Injection | 10 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| docetaxel | Injection | 40 mg/mL | |
| paclitaxel | Injection | 300 mg | |
| vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
| vincristine | Injection | 1 mg/mL | |
| vindesine (sulfate) | Powder for injection | 5 mg in 5 mL vial | |
| vinorelbine | Injection | 10 mg/mL | |
| vinorelbine | Injection | 50 mg (tartrate or ditartrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| capecitabine | Tablet | 500 mg | |
| citarabine | Injection | 100 mg in vial | |
| citarabine | Injection | 500 mg | |
| fludarabine | Injection | 50 mg (phosphate) | |
| fluorouracil | Cream | 5% | |
| fluorouracil | Injection | 500 mg in vial | |
| hydroxyurea | Capsule | 500 mg | |
| mercaptopurine | Tablet | 50 mg | |
| methotrexate | Injection | 500 mg | |
| methotrexate | Tablet | 2.5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| imatinib | Tablet | 400 mg (as mesylate) | |
| L-asparaginase | Injection | 500 IU in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bicalutamide | Tablet | 150 mg | |
| bicalutamide | Tablet | 50 mg | |
| ciproterone | Tablet | 50 mg (acetate) | |
| diethylstilbestrol | Tablet | 1 mg | |
| diethylstilbestrol | Tablet | 5 mg | |
| flutamide | Tablet | 250 mg | |
| goserelin | Injection | 10.8 mg | |
| goserelin | Injection | 3.6 mg | |
| letrozol | Tablet | 2.5 mg | |
| tamoxifen | Tablet | 20 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alemtuzumab | Injection | 30 mg in vial | |
| nimotuzumab | Injection | 50 mg in vial | |
| rituximab | Injection | 10 mg/mL in 10-mL vial | |
| rituximab | Injection | 10 mg/mL in 50-mL vial | |
| trastuzumab | Injection | 150 mg in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| BCG for immunotherapy | Injection | 50 mg in vial | |
| erythropoietin (recombinant) | Injection | 10 000 IU in vial | |
| thalidomide | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium folinate | Injection | equiv 50 mg folinic acid | |
| pamidronate disodium | Injection | 90 mg | |
| uromitexan | Injection | 400 mg in ampoule | |
| zoledronic acid | Injection | 4 mg in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ondansetron | Injection | 4 mg/mL in ampoule | |
| ondansetron | Tablet | 8 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amantadine | Capsule | 100 mg | |
| bromocriptine mesylate | Tablet | 2.5 mg | |
| levodopa + benserazide (or carbidopa) | Tablet | 200 mg + 50 mg | |
| levodopa single | Tablet | 500 mg | |
| pergolide mesylate | Tablet | 1 mg | |
| trihexyphenidyl | Tablet | 2 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ferrous fumarate | Powder for oral liquid | 150 mg/5 mL (equivalent 49.5 mg iron) | c2 |
| ferrous fumarate | Tablet (enteric-coated) | 200 mg (equivalent 66 mg iron) | |
| folic acid | Tablet | 1 mg | |
| folic acid | Tablet | 5 mg | |
| hydroxocobalamin | Injection | 0.1 mg/mL in 5-mL vial | |
| hydroxocobalamin | Injection | 1 mg/mL | |
| iron | Injection | 50 mg (dextran complex)/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| heparin sodium | Cream | 20 000 MIU/25 mg | |
| heparin sodium | Injection | 5000 IU/mL in 5-mL vial | |
| menadione sodium bisulfite (vitamin K3) | Injection | 2 mg/mL in 1-mL ampoule | |
| menadione sodium bisulfite (vitamin K3) | Injection | 25 mg/mL in 1-mL ampoule | |
| phytomenadione | Injection | 10 mg/mL in 1-mL ampoule | |
| warfarin | Tablet | 10 mg (sodium salt) | |
| warfarin | Tablet | 2 mg (sodium salt) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dextran 40 | Intravenous administration | 10% in 500-mL bottle | |
| dextran 70 | Intravenous administration | 6% in 400 mL bottle | |
| gelatin (liquid) | Solution for IV infusion | 4% in 500-mL bottle |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albumin | Solution for IV infusion | 20% in 50-mL bottle | |
| factor IX | Dried | 2000 IU in vial | |
| factor VIIa recombinant | Injection | 2.4 mg/vial (equivalent to 120 IU/vial) | |
| factor VIII concentrate | Dried | 250 IU |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diltiazem | Injection | 25 mg in 5-mL ampoule | |
| diltiazem | Tablet | 90 mg | |
| diltiazem | Tablet (prolonged release) | 120 mg | |
| glyceryl trinitrate | Injection | 5 mg in 5-mL ampoule | |
| glyceryl trinitrate | Tablet (sublingual) | 500 mcg | |
| isosorbide dinitrate | Tablet | 10 mg | |
| pentaerythrityl tetranitrate | Tablet | 10 mg | |
| pentaerythrityl tetranitrate | Tablet | 20 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| nimodipine | Capsule | 30 mg | |
| nimodipine | Injection | 10 mg/50 mL | |
| prostaglandin E | Injection | 0.5 mg/mL Prostaglandin E1 | c2 |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| adenosine | Injection | 3 mg/mL in 2-mL ampoule | |
| amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
| amiodarone | Tablet | 200 mg (hydrochloride) | |
| esmolol | Dried | 100 mg in 10 mL vial | |
| flecainide | Tablet | 100 mg | |
| magnesium sulfate | Injection | 10% | |
| procainamide | Injection | 100 mg (hydrochloride)/mL | |
| propafenone | Tablet | 150 mg | |
| quinidine | Tablet | 200 mg (sulfate) | |
| sotalol | Tablet | 160 mg | |
| sotalol | Tablet | 80 mg | |
| verapamil | Injection | 2.5 mg (hydrochloride)/mL in 2-mL ampoule | |
| verapamil | Tablet | 80 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amlodipine | Tablet | 10 mg | |
| atenolol | Injection | 0.5 mg/10 mL | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 25 mg | |
| captopril | Tablet | 25 mg | |
| captopril | Tablet | 50 mg | |
| dihydralazine sulfate | Injection | 20 mg/mL in 1-mL ampoule | |
| dihydralazine sulfate | Tablet | 50 mg | |
| enalapril | Tablet | 10 mg | |
| enalapril | Tablet | 20 mg | |
| labetalol | Injection | 5 mg (hydrochloride)/mL | |
| methyldopa | Tablet | 250 mg | |
| metoprolol | Tablet | 100 mg | |
| nifedipine | Tablet | 10 mg | |
| propanolol | Injection | 1 mg/mL | |
| propanolol | Tablet | 10 mg | |
| propanolol | Tablet | 40 mg | |
| reserpine | Tablet | 0.25 mg | |
| sodium nitroprusside | Injection | 20 mg/mL (2%) in 1-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carvedilol | Tablet | 12.5 mg | |
| digoxin | Injection | 0.5 mg in 2 mL ampoule | |
| digoxin | Tablet | 250 mcg | |
| milrinone | Injection | 1 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clopidogrel | Tablet | 75 mg | |
| dipyridamole | Injection | 10 mg in 2-mL ampoule | |
| dipyridamole | Tablet | 25 mg | |
| streptokinase | Powder for injection | 750,000 IU |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atorvastatine | Tablet | 10 mg (calcium salt) | |
| atorvastatine | Tablet | 20 mg | |
| cholestyramine | Powder for oral administration | 4-g sachet |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dobutamine | Injection | 250 mg in 25-mL vial | |
| dopamine | Injection | 200 mg (hydrochloride) in 5-mL ampoule | |
| dopamine | Injection | 50 mg in 1-mL ampoule | |
| epinephrine (adrenaline) | Injection | 1 mg in 1-mL ampoule | |
| isoprenaline | Injection | 0.2 mg in 1-mL ampule | |
| metaraminol | Injection | 10 mg in 1-mL ampoule | |
| norepinephrine | Injection | 8 mg in 4-mL ampoule | |
| phenylephrine | Injection | 10 mg in 1-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pentoxifylline | Injection | 300 mg in 15-mL ampoule | |
| pentoxifylline | Tablet | 400 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium dobesilate | Tablet | 250 mg | |
| diosmin | Tablet | 500 mg | |
| rutin + ascorbic acid | Tablet (enteric-coated) | 30 mg rutin + 50 mg ascorbic acid |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clotrimazole | Cream | 1% | |
| ketoconazole | Cream | 2% | |
| ketoconazole | Tablet | 200 mg | |
| ketoconazole | Vaginal tablet | 400 mg | |
| nystatin | Cream | 100 000 IU/g | |
| salicylic acid + benzoic acid + precipitated sulfur (Whitfield´s ointment with sulfur) | Ointment | 3 g salicylic acid+6 g bezoic acid+9 g precipitated sulfur | |
| tolnaftate | Cream | 1% | |
| undecylenic acid + zinc undecylenate | Ointment | 5 g undecylenic acid + 20 g zinc undecylenate per 25 g | |
| undecylenic acid + zinc undecylenate | Powder | 5 g undecylenic acid + 20 g zinc undecylenate per 100 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aciclovir | Cream | 5% | |
| bacitracin + neomycin | Cream | 50 000 IU bacitracin + 300 mg neomycin sulfate per 100 g | |
| gentamicin | Cream | 0.1% | |
| mafenide acetate | Cream | 10% | |
| metronidazole | Gel | 0.75% | |
| neomycin + corticoid | Cream | 350 mg neomycin sulfate + 500 mg prednisone per 100 g | |
| nitrofurazone | Cream | 0.2% | |
| silver sulfadiazine | Cream | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clobetasol | Cream | 0.05% | |
| clobetasol | Ointment | 25% | |
| triamcinolone | Cream | 0.1% triamcinolone acetonide |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| epidermal growth factor (human recombinant) | Intralesional injection | 0.025 mg in vial | |
| epidermal growth factor (human recombinant) | Intralesional injection | 0.075 mg in vial | |
| silver sulfadiazine + epidermal growth factor | Cream | 1 g silver sulfadiazine + 1 mg epidermal growth factor per 100 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| coal tar + resorcinol | Shampoo | 5 mL coal tar + 5 g resorcinol per 100 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzyl benzoate | Lotion | 10% | |
| permethrin | Cream | 5% | |
| permethrin | Lotion | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| DL-menthol + methyl salicylate | Cream | 0.09 g DL-menthol + 0.1 g methyl salicylate per gram | |
| placenta extract (human) | Lotion | 50% alcoholic placenta extract (human) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fluorescein | Injection | 10% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| barium sulfate | Powder for enema | 1000 g per flask | |
| iopamidol (iopromide) | Intravenous administration | Equiv 300 mg iodine in 20 mL-vial | |
| iopamidol (iopromide) | Intravenous administration | Equiv 370 mg iodine in 100 mL vial | |
| sodium diatrizoate | Intravenous administration | 500 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| boric acid + methyl salicylate + thymol | Solution for mouth rinse | 50 mg boric acid + 50 mg methyl salicylate + 60 mg thymol | |
| iodine-povidone | Solution | 10% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydrogen peroxide | Solution | 7% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorthalidone | Tablet | 25 mg | |
| furosemide | Injection | 20 mg/2 mL | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Tablet | 25 mg | |
| mannitol | Intravenous administration | 20% | |
| mannitol | Intravenous administration | 25% | |
| spironolactone | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cimetidine | Injection | 300 mg in 2-mL ampoule | |
| cimetidine | Tablet | 200 mg | |
| ranitidine | Injection | 25 mg/mL (as hydrochloride) in 2-mL ampoule | |
| ranitidine | Tablet | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| omeprazole | Capsule | 20 mg | |
| omeprazole | Injection | 40 mg in 10-mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| misoprostol | Tablet | 200 mcg | |
| misoprostol | Tablet | 25 mcg | |
| sucralfate | Tablet | 1 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dimenhydrinate | Injection | 50 mg/mL | |
| dimenhydrinate | Suppository | 100 mg | |
| dimenhydrinate | Tablet | 50 mg | |
| domperidone | Suspension | 10 mg/mL | |
| domperidone | Tablet | 10 mg | |
| metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
| metoclopramide | Oral liquid | 1 mg/mL | |
| metoclopramide | Tablet | 10 mg (hydrochloride) | |
| ondansetron | Injection | 4 mg/mL in ampoule | |
| ondansetron | Injection | 8 mg | |
| ondansetron | Tablet | 8 mg (chlorohydrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dibucaine (hydrochloride) + prednisone + allantoin | Rectal ointment | 500 mg dibucaine hydrochloride+250 mg prednisone+1 g allantoin per 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| mesalazine | Tablet (enteric-coated) | 400 mg | |
| salazosulfapyridine | Suppository | 500 mg salazosulfapyridine + 25 mg hydrocortisone acetate | |
| salazosulfapyridine | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Injection | 0.5 mg (sulphate) in 1-mL ampoule | |
| homatropine methylbromide | Oral liquid | 0.3 mg in 5 mL | |
| hyoscine butylbromide | Injection | 20 mg in 1-mL ampoule | |
| papaverine hydrochloride | Injection | 100 mg in 2-mL ampoule | |
| papaverine hydrochloride + homatropine methylbromide | Oral Solution (drops) | 40 mg papaverine hydrochloride + 2.5 mg homatropine methylbromide per mL | |
| papaverine hydrochloride + phenobarbital (sodium) + dypirone + homatropine methylbromide | Suppository | 100 g papaverine+15 mg phenobarbital+300 mg dypirone+2.5 mg homatropine |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bile salts | Tablet (enteric-coated) | 65 mg | |
| bisacodyl | Tablet (enteric-coated) | 5 mg | |
| glycerine | Suppository | 2.5 g (infants) | |
| glycerine | Suppository | 5 g (adults) | |
| ursodeoxycholic acid | Tablet | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diphenoxylate hydrochloride | Tablet | 2.5 mg diphenoxylate hydrochloride | |
| oral rehydration salts | Powder for oral administration | 26.8 g/L |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| charcoal, activated | Powder for oral administration | 1-kg bag | |
| charcoal, activated + pepsin | Tablet | 200 mg charcoal + 1.68 mg pepsin (1:3000) | |
| hydrochloric acid + pepsin | Oral Solution (drops) | 0.02 mL hydrochloric acid (diluted) + 100 mg pepsin (1:3000) in 1 mL | |
| pancreatin | Capsule | 10 000 U | |
| polidocanol | Intravenous administration | 0.5% in 20-mL ampoule | |
| polidocanol | Intravenous administration | 3% in 20-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone | Injection | 4 mg (sodium phosphate)/mL | |
| cortisone | Tablet | 25 mg (as acetate) | |
| dexamethasone | Injection | 4 mg (sodium phosphate) in 1-mL vial | |
| dexamethasone | Injection | 8 mg (as sodium phosphate) in 2-mL vial | |
| dexamethasone | Tablet | 0.75 mg | |
| dexamethasone | Tablet | 4 mg | |
| fludrocortisone | Tablet | 100 mcg (acetate) | |
| hydrocortisone | Powder for injection | 100 mg (sodium succinate) in 10-mL vial | |
| hydrocortisone | Powder for injection | 500 mg (sodium succinate) in 15-mL vial | |
| hydrocortisone | Tablet | 20 mg | |
| methylprednisolone | Injection | 40 mg (succinate) in 2-mL ampoule | |
| methylprednisolone | Powder for injection | 500 mg (succinate) in vial | |
| prednisolone | Injection | 30 mg (sodium phosphate)/mL in 2-mL vial | |
| prednisolone | Tablet | 20 mg (phosphate) | |
| prednisone | Tablet | 5 mg | |
| triamcinolone | Injection | 40 mg (acetonide)/mL in 5-mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chorionic gonadotropin (human) | Injection | 5000 IU/mL | |
| follicle-stimulating hormone (FSH) | Powder for injection | 75 IU | |
| goserelin | Injection | 10.8 mg | |
| goserelin | Injection | 10.8 mg | |
| triptorelin | Powder for injection | 3.75 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| zoledronic acid | Injection | 4 mg in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| danazol | Capsule | 200 mg | |
| desmopressin | Injection | 4 mcg (acetate)/mL | |
| desmopressin | Nasal solution | 0.1 mg (acetate)/mL | |
| glucagon | Injection | 1 mg/mL | |
| leuprorelin (leuprolide acetate) | Injection | 3.75 mg | |
| somatotropic hormone | Powder for injection | 5 mg in vial | |
| tetracosactide | Injection | 1 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| methandienone | Tablet | 25 mg | |
| testosterone | Depot injection | 100 mg (enanthate)/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ciproterone | Tablet | 50 mg (acetate) | |
| ciproterone + ethinylestradiol | Tablet (enteric-coated) | 2 mg + 0.05 mg | |
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 125 mcg | |
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 50 mcg | |
| ethinylestradiol + levonorgestrel | Tablet | 40 mcg + 75 mcg | |
| norethisterone enantate | Injection | 200 mg in 1-mL ampoule | |
| norethisterone enantate + estradiol valerate + | Injection | 50 mg + 5 mg in 1-mL ampoule | |
| norgestrel | Tablet | 0.03 mg | |
| norgestrel + ethinylestradiol | Tablet | 0.5 mg + 0.05 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| conjugated estrogens | Tablet | 0.625 mg | |
| conjugated estrogens | Vaginal cream | 25 g | |
| diethylstilbestrol | Tablet | 1 mg | |
| diethylstilbestrol | Tablet | 5 mg | |
| estradiol | Oily injection | 10 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| diazoxide | Tablet | 100 mg | |
| glibenclamide | Tablet | 5 mg | |
| metformin | Tablet | 500 mg (hydrochloride) | |
| NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL | |
| rapid acting insulin (ACTRAPID) | Injection | 100 IU in 10-mL vial | |
| rapid-acting insulin ASPART | Injection | 100 UI/mL in 10-mL vial | |
| tolbutamide | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clomifene | Tablet | 50 mg (citrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| medroxyprogesterone | Powder for injection | 150 mg in vial | |
| medroxyprogesterone | Powder for injection | 500 mg in vial | |
| medroxyprogesterone | Tablet | 5 mg | |
| medroxyprogesterone acetate | Tablet | 5 mg | |
| progesterone | Depot injection | 250 mg hydroxyprogesterone (caproate) in 1-mL ampoule | |
| progesterone | Injection | 25 mg hydroxyprogesterone (caproate) in 1-mL ampoule | |
| progesterone | Injection | 50 mg hydroxyprogesterone (caproate) in 1-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| levothyroxine | Injection | 200 mcg in ampoule | |
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine + liothyronine | Tablet | 100 mcg + 25 mcg | |
| methimazole | Tablet | 5 mg | |
| propylthiouracil | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bromocriptine mesylate | Tablet | 2.5 mg | |
| cabergoline | Tablet | 1 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tuberculin, purified protein derivative (PPD) | Subcutaneous administration | 2 TU/0.1 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anti-D immunoglobulin (human) | Injection | 250 mcg in single-dose vial | |
| antitetanus immunoglobulin (human) | Intramuscular administration | 250 IU per vial | |
| human normal immunoglobulin | Intramuscular administration | 10% protein solution in 2-mL vial | |
| human normal immunoglobulin | Intravenous administration | 5% protein solution | |
| human rabies immunoglobulin | Intramuscular administration | 1000 IU in 2-mL vial | |
| interferon alpha 2B | Injection | 10 000 000 IU | |
| interferon alpha 2B | Injection | 3 000 000 IU | |
| interferon alpha 2B | Injection | 5 000 000 IU | |
| interferon alpha-2A pegylated | Subcutaneous administration | 180 mcg in 0.5-mL vial | |
| interferon beta | Injection | 300 mcg | |
| transfer factor | Powder for injection | 1 U per vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| BCG vaccine | intradermal injection | 1 mg Mycobacterium bovis cells in 1-mL vial | |
| cell-culture rabies vaccine | Injection | N/A | |
| diphtheria, tetanus toxoid | Injection | 0.5 mL | |
| DTP vaccine | Injection | diphtheria-tetanus toxoid + whole inactivated B. pertussis cells | |
| Haemophilus influenzae type b vaccine (Hib vaccine) | Injection | 10 mcg PRP (synthetic) in 0.5 mL dose | |
| hepatitis B vaccine (recombinant) | Intramuscular administration | 10 mcg dose | |
| influenza vaccine | Injection | adult | |
| leptospirosis vaccine (trivalent) | Intramuscular administration | 50-80 million whole killed cells of each Canicola canicola, Icterohaemorrhagiae copenhageni and Pomona mozdok serovars in 0.5 mL dose | |
| meningococcal BC vaccine | Intramuscular administration | 50 mcg purified proteins (meningococcus B) + 50 mcg purified capsular polysaccharide (meningococcus C) in 0.5 mL dose | |
| MMR vaccine | Injection | measles, mumps and rubella live virus | |
| pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
| poliomyelitis vaccine | Oral liquid | N/A | |
| tetanus toxoid | Injection | 0.5 mL | |
| typhoid vaccine | Injection | 25 mcg Salmonella typhi Vi purified capsular polysaccharide in 0.5 mL dose |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| erythropoietin (recombinant) | Injection | 10 000 IU in vial | |
| erythropoietin (recombinant) | Injection | 4000 IU | |
| human recombinant granulocyte colony stimulating factor (G-CSF) | Injection | 300 mcg in vial | |
| thymus fraction | Injection | 1 mg/mL in 3-mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atracurium | Injection | 10 mg/mL (besylate) | |
| baclofen | Tablet | 10 mg | |
| dantrolene | Intravenous administration | 20 mg in vial | |
| methocarbamol | Tablet | 500 mg | |
| neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule | |
| pancuronium | Injection | 2 mg (bromuro)/mL | |
| physostigmine | Intravenous administration | 2 mg in 5-mL ampoule | |
| pyridostigmine | Tablet | 60 mg (bromide) | |
| succinylcholine chloride | Injection | 1 g in 20-mL vial | |
| succinylcholine chloride | Powder for injection | 1 g (lyophilized) in vial | |
| vecuronium | Injection | 4 mg (bromide)/mL in ampoule | |
| vecuronium | Powder for injection | 10 mg (bromide)/mL in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloramphenicol | Eye ointment | 1% | |
| chloramphenicol | Solution (eye drops) | 0.5% | |
| ciprofloxacin | Solution (eye drops) | 0.3% | |
| gentamicin | Solution (eye drops) | 0.3% (sulfate) | |
| idoxuridine | Solution (eye drops) | 1 mg/mL | |
| natamycin | Solution (eye drops) | 5% | |
| sulfacetamide | Solution (eye drops) | 20% | |
| tetracycline | Eye ointment | 0.5% (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fluorometholone + tetryzoline | Solution (eye drops) | 1 mg fluorometholone + 0.25 mg tetryzoline (hydrochloride) | |
| ketotifen | Solution (eye drops) | 0.025% (fumarate) | |
| prednisolone | Solution (eye drops) | 0.5% (sodium phosphate) | |
| sodium cromoglicate | Solution (eye drops) | 2% in 5-mL bottle |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tetracaine | Solution (eye drops) | 0.5% (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetazolamide | Intravenous administration | 500 mg in vial | |
| acetazolamide | Tablet | 250 mg | |
| dorzolamide | Solution (eye drops) | 2% (hydrochloride) | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride) | |
| pilocarpine | Solution (eye drops) | 4% (hydrochloride) | |
| timolol | Solution (eye drops) | 0.25% (maleate) | |
| timolol | Solution (eye drops) | 0.5% (maleate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcholine | Powder for dilution | 20 mg in 5-mL vial | |
| atropine | Solution (eye drops) | 0.5% (sulfate) | |
| atropine | Solution (eye drops) | 1% (sulfate) | |
| homatropine hydrobromide | Solution (eye drops) | 2% | |
| tropicamide | Solution (eye drops) | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzalkonium chloride | Solution (eye drops) | 0.01% | |
| cyanocobalamin | Solution (eye drops) | 0.02 mg/mL | |
| diclofenac | Solution (eye drops) | 0.1% (sodium) | |
| hydroxypropyl methylcellulose | Eye gel | 2 mg/10 g (artificial tears) | |
| methylcellulose | Solution (eye drops) | 5 mg/mL (artificial tears) | |
| sodium chloride hypertonic | Eye ointment | 5% | |
| sodium chloride hypertonic | Solution (eye drops) | 5% | |
| verteporfin | Intravenous administration | 15 mg in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ergometrine | Injection | 0.2 mg/mL (maleate) in 1-mL ampoule | |
| ethacridine | Powder for injection | 50 mg (lactate) in 15-mL vial | |
| oxytocin | Injection | 10 IU in 1-mL ampoule | |
| prostaglandin E | Injection | 0.5 mg prostaglandin E2 in ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| calcium resin | Powder for oral administration | 99 g calcium polystyrene sulfonate resin + 1 g vanilla in 100 g | |
| hemodialysis solution | Intravenous administration | concentrates, 20 L bottle | |
| hemodialysis solution (concentrated, acid, for bicarbonate hemodialysis) | Solution for IV infusion injection | NaCl 21.07 g, KCl 0,552 g, MgCl2 (6H2O) 0,355 g, CaCl2 (2H2O) 0.9 g, acetic acid / 100 mL | |
| HTK (Histidine-Tryptophan-Ketoglutarate) solution | Solution | sodium chloride (15 mmol)+potassium chloride (9 mmol)+potassium alpha-ketoglutarate (1 mmol)+magnesium chloride (4 mmol)+L-histidine hydrochloride (18 mmol)+L-histidine (180 mmol)+L-tryptophan (2 mmol)+mannitol (30 mmol)+calcium chloride (0.015 mmol) /L | |
| peritoneal dialysis solution | Peritoneal dialysis solution | 1.5% glucose, NaCl 567 mg, CaCl2 (2H2O) 25.7 mg, MgCl2 (6H2O) 15.2 mg, sodium lactate 392 mg / 100 mL | |
| sodium lactate, compound solution | Peritoneal dialysis solution | 1.5% (isotonic solution, Ringer solution) in 1 L bottle | |
| sodium lactate, compound solution | Peritoneal dialysis solution | 2.5% (hypertonic solution) | |
| sodium resin | Powder for oral administration | 99 g sodium sulfonated polystyrene resin + 1 g vanilla in 100 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg (hydrochloride) in 1-mL ampoule | |
| chlorpromazine | Injection | 50 mg/2 mL | |
| chlorpromazine | Oral liquid | 10 mg/mL | |
| chlorpromazine | Tablet (enteric-coated) | 100 mg (hydrochloride) | |
| chlorpromazine | Tablet (enteric-coated) | 25 mg (hydrochloride) | |
| dehydrobenzperidol | Injection | 2.5 mg/mL in 10-mL vial | |
| fluphenazine | Injection | 25 mg (decanoate)/mL | |
| fluphenazine | Tablet | 2.5 mg (hydrochloride) | |
| haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
| haloperidol | Tablet | 1.5 mg | |
| levomepromazine | Tablet | 25 mg (maleate) | |
| olanzapine | Tablet | 10 mg | |
| olanzapine | Tablet | 5 mg | |
| pimozide | Tablet | 1 mg | |
| pimozide | Tablet | 4 mg | |
| quetiapine | Tablet | 200 mg (fumarate) | |
| thioridazine | Tablet (enteric-coated) | 25 mg | |
| trifluoperazine | Tablet | 1 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amitriptyline | Tablet (enteric-coated) | 25 mg (hydrochloride) | |
| imipramine | Injection | 25 mg (hydrochloride)/2 mL | |
| imipramine | Tablet (enteric-coated) | 25 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sertraline | Tablet | 50 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| lithium carbonate | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alprazolam | Oral liquid | 0.5 mg/0.5 mL | |
| alprazolam | Tablet | 500 mcg | |
| chloral hydrate | Oral liquid | 600 mg/5 mL | |
| chlordiazepoxide | Tablet | 10 mg | |
| clobazam | Tablet | 20 mg | |
| clonazepam | Tablet | 1 mg | |
| diazepam | Injection | 10 mg in 2-mL ampoule | |
| diazepam | Tablet | 5 mg | |
| flunitrazepam | Injection | 2 mg in vial | |
| medazepam | Tablet | 10 mg | |
| meprobamate | Tablet | 400 mg | |
| midazolam | Injection | 5 mg/mL | |
| nitrazepam | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| caffeine + sodium benzoate | Injection | caffeine (anhydrous) 250 mg + sodium benzoate 250 mg in 1-mL ampoule | |
| methylphenidate | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acamprosate | Tablet | 333 mg (calcium) | |
| clonidine | Tablet | 300 mcg | |
| disulfiram | Tablet | 500 mg | |
| naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
| naltrexone | Tablet | 50 mg (hydrochloride) | |
| tianeptine | Tablet | 12.5 mg (sodium) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| salbutamol | Injection | 0.5 mg/mL | |
| salbutamol | Metered dose inhaler (aerosol) | 0.1 mg/dose | |
| salbutamol | Oral liquid | 2 mg/5 mL | |
| salbutamol | Respirator solution for use in nebulizers | 5 mg/mL | |
| salbutamol | Tablet | 2 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aminophylline | Injection | 25 mg/mL | |
| theophylline | Tablet | 170 mg | |
| theophylline | Tablet (prolonged release) | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| beclometasone | Metered dose inhaler (aerosol) | 250 mcg (dipropionate) per dose | |
| beclometasone | Metered dose inhaler (aerosol) | 50 micrograms (dipropionate) per dose |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| montelukast | Tablet | 10 mg | |
| montelukast | Tablet (chewable) | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| lung surfactant (natural) | Solution for intratracheal administration | 50 mg in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylcysteine | Injection | 20% | |
| acetylcysteine | Powder for oral administration | 200 mg | |
| ephedrine | Nasal solution | 1% | |
| nikethamide | Injection | 375 mg in 2-mL ampoule | |
| paracetamol + chlorpheniramine | Tablet (enteric-coated) | 325 mg paracetamol + 2 mg chlorpheniramine (maleate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oral rehydration salts | Powder for oral administration | 26.8 g/L | |
| potassium chloride | Oral liquid | 20% or 3 g/15 mL (40 mEq potassium) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amino acids | Parenteral formulation | 10% | |
| calcium chloride | Injection | 10% in 10-mL vial | |
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
| glucose | Injection | 50% (20 mL) | |
| glucose | Parenteral formulation | 10% (500 mL) | |
| glucose | Parenteral formulation | 5% (1000 mL) | |
| glucose | Parenteral formulation | 5% (500 mL) | |
| glucose | Parenteral solution | 20% (10 mL) | |
| glucose | Parenteral solution | 30% (500 mL) | |
| glucose | Parenteral solution | 5% (10 mL) | |
| glucose | Parenteral solution | 50% (100 mL) | |
| lipid emulsion | Emulsion | 10% | |
| magnesium sulfate | Injection | 10% | |
| potassium chloride | Parenteral solution | 25 mEq/10 mL in ampoule | |
| potassium gluconate | Injection | 30% in 20-mL ampoule | |
| sodium bicarbonate | Injection | 8% | |
| sodium bicarbonate | Parenteral solution | 4% | |
| sodium chloride | Parenteral solution | 0.9% 1000-mL bottle | |
| sodium chloride | Parenteral solution | 0.9% in 250-mL plastic bag | |
| sodium chloride | Parenteral solution | 0.9% in 500-mL bottle | |
| water for injection | Injection | 5 mL in ampoule | |
| water for injection | Injection | 500 mL-bottle |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ascorbic acid | Oral Solution (drops) | 7 mg per drop | |
| ascorbic acid | Solution for injection | 100 mg/mL | |
| ascorbic acid | Tablet | 500 mg | |
| calcium carbonate | Tablet | 500 mg | |
| cooper sulfate | Injection | 5 mg/mL | |
| ergocalciferol | Injection | 200 000 IU/mL | |
| ergocalciferol | Oral Solution (drops) | 100 000 IU/mL | |
| ferrous fumarate + folic acid | Tablet | 25 mg ferrous fumarate (24 mg iron) + 0.1 mg folic acid | c2 |
| nicotinamide | Tablet | 50 mg | |
| retinoic acid | Capsule | 10 mg | |
| riboflavin | Tablet | 5 mg | |
| thiamine | Injection | 100 mg/mL | |
| thiamine | Tablet | 50 mg (hydrochloride) | |
| vitamin A | Tablet | 25 000 IU | |
| vitamin A + D | Oral Solution (drops) | 25 000 IU vitamin A (retinol) + 2000 IU vitamin D2 (ergocalciferol) per mL | |
| vitamin B complex | Oral liquid | 2 mg thiamine (hydrochloride), 0.3 mg riboflavin, 20 mg niacin/5 mL | |
| vitamin B12 | Injection | 10 mg/mL in 5-mL vial | |
| vitamin complex | Injection | 100 mg thiamine (hydrochloride), 100 mg pyridoxine, 5 mg cyanocobalamin in vial | |
| vitamin complex | Oral Solution (drops) | 2 mg thiamine (hydrochloride), 4.1 mg riboflavin, 20 mg niacin, 5000 IU Vitamin A, 400 IU Vitamin D2 per mL | |
| vitamin complex | Tablet | 2.5 mg thiamine, 1.6 mg riboflavin, 20 mg niacin, 0.25 mg folic acid, 2 mg pyridoxine, 250 IU retinol, 0.06 mg cyanocobalamin | |
| vitamin E | Tablet | 100 mg | |
| zinc sulfate | Intravenous administration | 22 mg/mL | |
| zinc sulfate | Oral liquid | 10 mg/5 mL | |
| zinc sulfate | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| biotin | Tablet | 5 mg | |
| L-carnitine | Oral liquid | 300 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oxybutynin | Tablet | 5 mg | |
| potassium citrate | Tablet | 1.08 g (10 mEq) | |
| sildenafil | Tablet (enteric-coated) | 50 mg (citrate) | |
| terazosin | Tablet | 2 mg | |
| terazosin | Tablet | 5 mg |